NIH Grant to Advance Lung Therapeutics’ Empyema Drug Therapy
$1.69 million award will go to develop LTI-01 for treatment of pleural effusion with loculation. The National Institutes of Health (NIH) will support research conducted by Dr. Steven Idell, MD, PhD, who serves as UT Health Northeast investigator and chief scientific officer of the pharmaceutical company Lung Therapeutics, Inc.
by Leonor Mateus Ferreira
LUNG DISEASE NEWS